Level D· Scientific groundwork from lab and animal studiesNarrative ReviewPubMedOpen access

M2-like macrophages serve as a niche for adipocyte progenitors in adipose tissue.

Nawaz A., Tobe K.

Narrative Review on Type 2 Diabetes, Chronic Inflammation, published in J Diabetes Investig (2019) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
J Diabetes Investig (2019)
Country
Japan
Reported sample size
—
Source database
PubMed
PMID
31293080
PMCID
PMC6825922
DOI
10.1111/jdi.13114
Citations
29

Abstract (original English)

Adipose tissue (AT) is composed not only of adipocytes, but also of macrophages, endothelial cells and preadipocytes. Macrophages are an important component of AT, and are involved in tissue homeostasis, tissue repair and fibrosis. AT-resident macrophages are categorized into two subtypes, the M1-like and M2-like macrophages. M2-like macrophages are reported to play anti-inflammatory roles, and to be involved in clearing and removal of dying/dead adipocytes, and recruiting adipocyte progenitors (APs). M2-like macrophages are also reported to be involved in the promotion of fibrosis in a transforming growth factor-β-dependent manner. However, the precise roles of M2-like macrophages in the AT have not yet been clearly delineated. Recently, we generated genetically engineered transgenic mice in which CD206 + M2-like macrophages can be conditionally depleted. Unexpectedly, we found that the depletion of CD206 + M2-like macrophages resulted in the enhanced generation of smaller adipocytes, improved insulin sensitivity and proliferation of APs. We further clarified that the CD206 + M2-like macrophages directly interact with the APs to regulate their growth/differentiation and adipogenesis, thereby controlling adiposity and systemic insulin sensitivity. In the present review, we discuss how CD206 + M2-like macrophages provide a niche for APs and maintain glucose homeostasis.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AdipocytesAdipose TissueAnimalsCell DifferentiationGlucoseHomeostasisHumansInsulin ResistanceMacrophagesStem Cells

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research